Dr Reddy’s Laboratories Share Price Falls 2.83% to Rs 1149.3 After Q1 Results
- July 23, 2026
- Posted by: Ankit Jaiswal
- Category: News
Dr Reddy’s Laboratories CMP Rs 1149.3, -2.83% as of 23 Jul 2026. Q1 FY27 results announced 22 July 2026. PAT Rs 436 crore, -69.1% YoY. Revenue Rs 8455 crore, -4.6% YoY.
Dr Reddy’s Laboratories share price fell 2.83% to trade at Rs 1149.3 as of 23 July 2026, after the company announced its Q1 FY27 results on 22 July 2026.
The company reported revenue of Rs 8455 crore, down 4.6% year on year and a net profit of Rs 436 crore, down 69.1% year on year for the quarter ended 30 June 2026.
Click Here – Get Free Investment Predictions
Dr Reddy’s Laboratories Q1 FY27 Results Snapshot
| Metric | Q1 FY26 | Q1 FY27 | YoY Change |
|---|---|---|---|
| Revenue | Rs 8862 Cr | Rs 8455 Cr | -4.6% |
| Net Profit (PAT) | Rs 1410 crore | Rs 436 crore | -69.1% |
Dr Reddy’s Laboratories is a pharmaceuticals company listed on the Indian stock exchanges. Severe profit miss on US generics pricing pressure and a semaglutide API issue
Learn More About Univest, a SEBI Registered Investment Advisor
Why Dr Reddy’s Laboratories Moved After Q1 Results
A sharp 69.1% year on year decline in profit weighed on sentiment. Revenue declined 4.6% year on year, a headwind that investors are weighing against the bottom line performance.
Trading volumes in Dr Reddy’s Laboratories were also elevated around the results announcement, a typical pattern when a stock re-rates on fresh quarterly numbers rather than moving purely on broader index cues. Investors reading the print alongside sector peers get a fuller picture of whether the move is company specific or part of a wider sector trend.
Broader Market Context
The reaction in Dr Reddy’s Laboratories shares also comes against a backdrop of a broader Indian market that has been volatile this week, with global cues including rising crude oil prices on US-Iran tensions and a weak yen weighing on sentiment across sectors. Stock specific results commentary should be read alongside this wider market context rather than in isolation.
Sector peers of Dr Reddy’s Laboratories in the pharmaceuticals space have also seen mixed reactions this results season, underlining that stock specific execution and margin trends are driving individual outcomes more than broad sector sentiment alone.
Download the Univest iOS App or Univest Android App to track Dr Reddy’s Laboratories live price and get daily stock recommendations.
What Investors Should Watch Next
Investors tracking Dr Reddy’s Laboratories should watch for management commentary on the post-results earnings call, any changes in brokerage ratings or price targets, and the stock’s technical support and resistance levels in the sessions following results.
Use the Univest Screener to compare Dr Reddy’s Laboratories against sector peers on valuation and growth metrics before making any investment decision. Longer term investors may also want to track how the company’s guidance for the rest of FY27 evolves over the coming quarters.
Conclusion
Dr Reddy’s Laboratories fell 2.83% following its Q1 FY27 results announced on 22 July 2026. A sharp 69.1% year on year decline in profit weighed on sentiment. Investors should track further brokerage commentary and the company’s next quarterly update, and consult a SEBI-registered advisor before making any investment decision.
Dr Reddy’s Laboratories share price remains a key data point for investors this week.
Tracking Dr Reddy’s Laboratories share price closely can help investors time entries around results season volatility.
The Dr Reddy’s Laboratories share price move today adds to a busy week of Q1 FY27 earnings reactions across the market.
Dr Reddy’s Laboratories share price trends will be watched alongside sector peers reporting results this week.
Analysts covering Dr Reddy’s Laboratories share price action will likely publish updated notes in the coming days.
Dr Reddy’s Laboratories share price has been in focus given the scale of today’s move.
Traders watching Dr Reddy’s Laboratories share price today are also weighing broader index direction.
The Dr Reddy’s Laboratories share price reaction underscores how sensitive the stock is to quarterly earnings surprises.
Dr Reddy’s Laboratories share price volatility around results is typical for stocks with active retail participation.
Keeping an eye on Dr Reddy’s Laboratories share price over the next few sessions will clarify if the move sustains.
Dr Reddy’s Laboratories share price is one of several results-linked movers investors are tracking today.
Momentum in Dr Reddy’s Laboratories share price could shift quickly if fresh brokerage notes are published.
Dr Reddy’s Laboratories share price remains a key data point for investors this week.
Tracking Dr Reddy’s Laboratories share price closely can help investors time entries around results season volatility.
The Dr Reddy’s Laboratories share price move today adds to a busy week of Q1 FY27 earnings reactions across the market.
Dr Reddy’s Laboratories share price trends will be watched alongside sector peers reporting results this week.
Analysts covering Dr Reddy’s Laboratories share price action will likely publish updated notes in the coming days.
Dr Reddy’s Laboratories share price has been in focus given the scale of today’s move.
Traders watching Dr Reddy’s Laboratories share price today are also weighing broader index direction.
The Dr Reddy’s Laboratories share price reaction underscores how sensitive the stock is to quarterly earnings surprises.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Dr Reddy’s Laboratories After Q1 Results
Why did Dr Reddy’s Laboratories share price fall after Q1 results?
Ans. Dr Reddy’s Laboratories fell 2.83% following its Q1 FY27 results announced on 22 July 2026. A sharp 69.1% year on year decline in profit weighed on sentiment.
What was Dr Reddy’s Laboratories’s Q1 FY27 profit figure?
Ans. Dr Reddy’s Laboratories reported a net profit of Rs 436 crore in Q1 FY27, down 69.1% year on year.
What was Dr Reddy’s Laboratories’s Q1 FY27 revenue?
Ans. Dr Reddy’s Laboratories reported revenue of Rs 8455 crore in Q1 FY27, down 4.6% year on year.
When did Dr Reddy’s Laboratories announce its Q1 FY27 results?
Ans. Dr Reddy’s Laboratories announced its Q1 FY27 results on 22 July 2026, for the quarter ended 30 June 2026.
What is the current price of this stock?
Ans. Dr Reddy’s Laboratories was trading at Rs 1149.3 as of 23 July 2026, down 2.83% for the session.
Should I buy this stock after the Q1 results reaction?
Ans. This article is for informational purposes only and is not investment advice. Investors should evaluate the results in the context of their own portfolio and consult a SEBI-registered investment advisor before making any investment decision.
Where can I track live price and updates?
Ans. Investors can track Dr Reddy’s Laboratories’s live share price, Q1 FY27 results details and analyst commentary on the Univest platform.
